California Public Employees Retirement System Esperion Therapeutics, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$19.4 - $28.71 $1.02 Million - $1.52 Million	-52,800 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$24.2 - $35.76 $26,620 - $39,336	-1,100 Reduced 2.04%	52,800 $1.37 Million
Q3 2020 Nov 05, 2020	SELL	$31.18 - $52.71 $103,361 - $174,733	-3,315 Reduced 5.79%	53,900 $2 Million
Q2 2020 Aug 12, 2020	BUY	$30.04 - $51.31 $24,032 - $41,048	800 Added 1.42%	57,215 $2.94 Million
Q1 2020 May 12, 2020	SELL	$27.44 - $73.84 $8,232 - $22,152	-300 Reduced 0.53%	56,415 $1.78 Million
Q4 2019 Jan 27, 2020	BUY	$35.4 - $59.82 $375,310 - $634,211	10,602 Added 22.99%	56,715 $3.38 Million
Q3 2019 Oct 31, 2019	BUY	$34.47 - $47.53 $484,855 - $668,556	14,066 Added 43.89%	46,113 $1.69 Million
Q2 2019 Aug 15, 2019	BUY	$40.1 - $52.33 $194,364 - $253,643	4,847 Added 17.82%	32,047 $1.49 Million
Q1 2019 May 03, 2019	SELL	$40.11 - $53.57 $28,077 - $37,499	-700 Reduced 2.51%	27,200 $1.09 Million
Q4 2018 Feb 08, 2019	SELL	$36.99 - $59.11 $51,786 - $82,754	-1,400 Reduced 4.78%	27,900 $1.28 Million
Q3 2018 Nov 13, 2018	SELL	$40.74 - $51.41 $210,951 - $266,200	-5,178 Reduced 15.02%	29,300 $1.3 Million
Q2 2018 Aug 15, 2018	SELL	$36.2 - $76.4 $384,226 - $810,909	-10,614 Reduced 23.54%	34,478 $1.35 Million
Q1 2018 May 11, 2018	SELL	$65.94 - $80.76 $248,330 - $304,142	-3,766 Reduced 7.71%	45,092 $3.26 Million
Q4 2017 Feb 06, 2018	BUY	$43.47 - $67.43 $30,429 - $47,201	700 Added 1.45%	48,858 $3.22 Million
Q3 2017 Nov 15, 2017	BUY	$43.8 - $52.77 $2.11 Million - $2.54 Million	48,158	48,158 $2.41 Million

Others Institutions Holding ESPR

# of Institutions

207

Shares Held

128M

Call Options Held

1.67M

Put Options Held

930K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $155M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account